Ribupatide

Ribupatide (HRS9531) is an oral dual GLP‑1/GIP receptor agonist that demonstrates potent glycemic control and clinically meaningful weight‑loss efficacy in obesity and type 2 diabetes trials.

Amino-acid Sequence

HRS9531

CAS No. 2940971-65-1

当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

製品安全説明書

現在のバッチを見る: P127401 DMSO] 100 mg/mL] false] Water] Insoluble] false] Ethanol] Insoluble] false 純度: 96.08%
96.08

化学情報

保管

In vitro
Batch:

DMSO : 100 mg/mL ( ; 吸湿したDMSOは溶解度を減少させます。新しいDMSOをご使用ください。)

Water : Insoluble

Ethanol : Insoluble

モル濃度計算器

in vivo
Batch:

Add solvents to the product individually and in order.

投与溶液組成計算機

生物活性

製品説明 HRS9531 (ribupatide) is an oral dual GLP‑1/GIP receptor agonist that demonstrates potent glycemic control and clinically meaningful weight‑loss efficacy in obesity and type 2 diabetes trials.
  • https://diabetesjournals.org/diabetes/article/74/Supplement_1/797-P/158958

製品情報

Molecular Formula

C229H346N48O71

CAS No. 2940971-65-1
Shipping Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)